Temenos: Deal timing impacts Q2, but FY26 guidance reaffirmed

Research evidence excerpt

Temenos: Deal timing impacts Q2, but FY26 guidance reaffirmed

luded in this publication. Barclays may provide research to certain

categories of recipients that do not use it for investment purposes, including public and private companies in covered industries, media organisations,

regulators, and academic institutions that use such research for their own internal informational, news gathering, regulatory or academic purposes. To

the extent that this publication states on the front page that it is intended for institutional investors and is not subject to all of the independence and

disclosure standards applicable to debt research reports prepared for retail investors under U.S. FINRA Rule 2242, it is an “institutional debt research

report” and distribution to retail investors is strictly prohibited. Media organisations are prohibited from re-publishing any opinion or recommendation

concerning a debt issuer or debt security contained in any Barclays institutional debt research report. Any recipients that do not want to continue

receiving Barclays institutional debt research reports should contact debtresearch@barclays.com. Unless clients have agreed to receive “institutional

debt research reports” as required by US FINRA Rule 2242, they will not receive any such reports that may be co-authored by non-debt research

analysts. Eligible clients may get access to such cross asset reports by contacting debtresearch@barclays.com. Barclays will not treat unauthorized

recipients of this report as its clients and accepts no liability for use by them of the contents which may not be suitable for their personal use. Prices

shown are indicative and Barclays is not offering to buy or sell or soliciting offers to buy or sell any financial instrument.